A Study of Cannabidiol in Young Adult Cannabis Users
Part of paid clinical trials in Aurora, Colorado.
- Sponsor
- University of Colorado, Denver
- Study ID
- NCT06569394
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- Cannabis Use Disorder
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 25 Years
- Healthy Volunteers
- Not accepted
Interventions
- Broad Spectrum Cannabidiol (bsCBD) 400 mg — DRUGParticipants in this Arm will take 400 mg of bsCBD daily. Participants will take medication by mouth with food in the morning and evening.
- Placebo — DRUGParticipants in this Arm will take a medically inert placebo. Participants will take medication by mouth with food in the morning and evening.
Study Details
The investigators will study the harm-reducing effect of hemp-derived CBD in non-treatment-seeking emerging adults who use cannabis regularly. The study will use a novel naturalistic cannabis administration approach, which examines ecologically valid cannabis use utilizing a mobile lab setting to assess the effects of the cannabis products the participants regularly use. The investigators will recruit a sample of emerging adults, half of whom primarily use flower products and half of whom primarily use concentrate products. Individuals will be randomly assigned to hemp-derived CBD or placebo.
Key Dates
- Start date
- Dec 9, 2024
- Status verified
- Apr 2026
- Primary completion
- Jun 30, 2028
- Completion
- Jun 30, 2028
Study Design
- Enrollment
- 200 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- OTHER
Arms
- Active Comparator: Broad Spectrum Cannabidiol (bsCBD) 400 mgbsCBD in a 400 mg dose will be used as described in the study arms.
- Placebo Comparator: PlaceboA medically inert placebo medication will be used as described in the study arms.
Primary Outcome Measure
Difference in blood THC-COOH levels [ Time Frame: 8 weeks ]
Central Contacts
- Christian J Hopfer, MD303-724-3170
- Kristen M Raymond, BA303-724-3196
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Colorado Anschutz Medical Campus | Aurora | Colorado | 80045 |
Find similar trials in Aurora, CO
By research site
Related Studies
- Longitudinal Outpatient Treatment for Cannabis Use DisorderPHASE2 · Recruiting · University of Colorado, Boulder · Boulder, Colorado
- Effects of THC on Alcohol Consumption and Neural Correlates of RewardPHASE2 · Recruiting · University of Colorado, Denver · Aurora, Colorado
- Cannabidiol and Cannabis Concentrate UsersPHASE2 · Recruiting · University of Colorado, Denver · Aurora, Colorado
- SV2 PET Imaging With [11C]APP311Recruiting · Yale University · New Haven, Connecticut